Matches in SemOpenAlex for { <https://semopenalex.org/work/W3172566969> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W3172566969 endingPage "S499" @default.
- W3172566969 startingPage "S498" @default.
- W3172566969 abstract "Abstract Background We sought to define the effectiveness of tofacitinib in a real-world (RW) cohort of patients with moderate to severe ulcerative colitis (UC). Methods This was a multi-center retrospective observational cohort study (2017–2020). Clinical response and remission were defined as a reduction in Simple Clinical Colitis Activity Index (SCCAI) or partial Mayo score (PMS) of ≥3, and SCCAI ≤2 or a PMS ≤1, respectively. Results We included 73 patients (47% male; median age 26 years [IQR 19.5–39.5], disease duration 7 years [IQR 2.5–14.5], follow-up 7.1 months [IQR 3–12]), 91% biologics-experienced, and 74% ≥ 2-biologics. Half of patients used concomitant steroids. Overall, 56.1% discontinued therapy due to either lack of response and/or adverse events (AEs), median time to discontinuation - 9.7 months (IQR 3.4–16). Based on per-protocol analysis, after induction (week-8–16), 33.3% achieved response, 23.3% remission, and 19% corticosteroid free remission. At early maintenance (week 26), 50% achieved response, 26.8% remission, and 24.4% corticosteroid free remission. There were no differences between biologics-experienced and naïve patients. Seventeen patients (23.2%) had an AE: herpes zoster- 2.7%, hospitalization- 12.3%, and colectomy- 2.7%. Remitters had higher albumin level compared with non-remitters (4.2±0.35 Vs. 3.8±0.35, P=0.023, respectively). Conclusion In this multicenter RW cohort of highly biologics - experienced patients with UC, those who continued tofacitinib throughout induction achieved 50% response and 27% remission. Tofacitinib was well-tolerated." @default.
- W3172566969 created "2021-06-22" @default.
- W3172566969 creator A5001492832 @default.
- W3172566969 creator A5015507512 @default.
- W3172566969 creator A5029273084 @default.
- W3172566969 creator A5033531513 @default.
- W3172566969 creator A5041153897 @default.
- W3172566969 creator A5044542949 @default.
- W3172566969 creator A5065383969 @default.
- W3172566969 creator A5069738170 @default.
- W3172566969 creator A5070365540 @default.
- W3172566969 creator A5071427865 @default.
- W3172566969 creator A5072937522 @default.
- W3172566969 creator A5077708857 @default.
- W3172566969 creator A5078184286 @default.
- W3172566969 creator A5079488262 @default.
- W3172566969 creator A5080002704 @default.
- W3172566969 creator A5084627690 @default.
- W3172566969 creator A5090724885 @default.
- W3172566969 date "2021-05-01" @default.
- W3172566969 modified "2023-09-23" @default.
- W3172566969 title "P522 Effectiveness of tofacitinib in a real-world Israeli cohort of patients with moderate-severe ulcerative colitis" @default.
- W3172566969 doi "https://doi.org/10.1093/ecco-jcc/jjab076.644" @default.
- W3172566969 hasPublicationYear "2021" @default.
- W3172566969 type Work @default.
- W3172566969 sameAs 3172566969 @default.
- W3172566969 citedByCount "0" @default.
- W3172566969 crossrefType "journal-article" @default.
- W3172566969 hasAuthorship W3172566969A5001492832 @default.
- W3172566969 hasAuthorship W3172566969A5015507512 @default.
- W3172566969 hasAuthorship W3172566969A5029273084 @default.
- W3172566969 hasAuthorship W3172566969A5033531513 @default.
- W3172566969 hasAuthorship W3172566969A5041153897 @default.
- W3172566969 hasAuthorship W3172566969A5044542949 @default.
- W3172566969 hasAuthorship W3172566969A5065383969 @default.
- W3172566969 hasAuthorship W3172566969A5069738170 @default.
- W3172566969 hasAuthorship W3172566969A5070365540 @default.
- W3172566969 hasAuthorship W3172566969A5071427865 @default.
- W3172566969 hasAuthorship W3172566969A5072937522 @default.
- W3172566969 hasAuthorship W3172566969A5077708857 @default.
- W3172566969 hasAuthorship W3172566969A5078184286 @default.
- W3172566969 hasAuthorship W3172566969A5079488262 @default.
- W3172566969 hasAuthorship W3172566969A5080002704 @default.
- W3172566969 hasAuthorship W3172566969A5084627690 @default.
- W3172566969 hasAuthorship W3172566969A5090724885 @default.
- W3172566969 hasConcept C126322002 @default.
- W3172566969 hasConcept C167135981 @default.
- W3172566969 hasConcept C197934379 @default.
- W3172566969 hasConcept C2776694085 @default.
- W3172566969 hasConcept C2777575956 @default.
- W3172566969 hasConcept C2778260677 @default.
- W3172566969 hasConcept C2778283404 @default.
- W3172566969 hasConcept C2778715236 @default.
- W3172566969 hasConcept C2778886723 @default.
- W3172566969 hasConcept C2779134260 @default.
- W3172566969 hasConcept C2779384505 @default.
- W3172566969 hasConcept C2780479503 @default.
- W3172566969 hasConcept C71924100 @default.
- W3172566969 hasConcept C72563966 @default.
- W3172566969 hasConcept C90924648 @default.
- W3172566969 hasConceptScore W3172566969C126322002 @default.
- W3172566969 hasConceptScore W3172566969C167135981 @default.
- W3172566969 hasConceptScore W3172566969C197934379 @default.
- W3172566969 hasConceptScore W3172566969C2776694085 @default.
- W3172566969 hasConceptScore W3172566969C2777575956 @default.
- W3172566969 hasConceptScore W3172566969C2778260677 @default.
- W3172566969 hasConceptScore W3172566969C2778283404 @default.
- W3172566969 hasConceptScore W3172566969C2778715236 @default.
- W3172566969 hasConceptScore W3172566969C2778886723 @default.
- W3172566969 hasConceptScore W3172566969C2779134260 @default.
- W3172566969 hasConceptScore W3172566969C2779384505 @default.
- W3172566969 hasConceptScore W3172566969C2780479503 @default.
- W3172566969 hasConceptScore W3172566969C71924100 @default.
- W3172566969 hasConceptScore W3172566969C72563966 @default.
- W3172566969 hasConceptScore W3172566969C90924648 @default.
- W3172566969 hasIssue "Supplement_1" @default.
- W3172566969 hasLocation W31725669691 @default.
- W3172566969 hasOpenAccess W3172566969 @default.
- W3172566969 hasPrimaryLocation W31725669691 @default.
- W3172566969 hasRelatedWork W2054713040 @default.
- W3172566969 hasRelatedWork W2755978387 @default.
- W3172566969 hasRelatedWork W2800521242 @default.
- W3172566969 hasRelatedWork W2887641776 @default.
- W3172566969 hasRelatedWork W2944375061 @default.
- W3172566969 hasRelatedWork W2980200688 @default.
- W3172566969 hasRelatedWork W2981478968 @default.
- W3172566969 hasRelatedWork W3023801138 @default.
- W3172566969 hasRelatedWork W4225292413 @default.
- W3172566969 hasRelatedWork W4294710519 @default.
- W3172566969 hasVolume "15" @default.
- W3172566969 isParatext "false" @default.
- W3172566969 isRetracted "false" @default.
- W3172566969 magId "3172566969" @default.
- W3172566969 workType "article" @default.